Boston keratoprosthesis type 1 for limbal stem cell deficiency after severe chemical corneal injury: A systematic review.
CONCLUSIONS: Implantation of a Boston keratoprosthesis type I in eyes with corneal blindness after severe chemical ocular injury leads to functional vision in the majority of recipients. Evidence was limited by variability in outcome reporting and an absence of controlled studies..
PMID: 29597010 [PubMed - as supplied by publisher]
Source: The Ocular Surface - Category: Opthalmology Authors: Shanbhag SS, Saeed HN, Paschalis EI, Chodosh J Tags: Ocul Surf Source Type: research
More News: Blindness | Brain | Chemistry | Eyes | Neurology | Neuroscience | Opthalmology | Science | Stem Cell Therapy | Stem Cells | Study